SecBot SecBot
Home › SEC Filings › Current Report (8-K)

Current Report (8-K)

10,000+ reports analyzed by SecBot AI · browse by date or by stock
TickerTypeSentimentImpactSummaryDate
NDSN8-Kneutral4/10Nordson completed the acquisition of Contrinex Holding SA for approximately $168 million in enterprise value, adding a SOct 23, 2026
MBOT8-Kneutral2/10Microbot Medical filed an 8-K announcing its attendance at the SIR EDGE 2026 conference (Oct 25-27) and the concurrent AOct 23, 2026
LSBK8-Kneutral2/10Lake Shore Bancorp declared a quarterly cash dividend of $0.09 per share, payable November 11, 2026 to shareholders of rOct 23, 2026
GEG8-Kneutral3/10Director Eric Scheyer notified Great Elm Group's board on October 21, 2026 that he will not stand for re-election at theOct 23, 2026
BR8-Kneutral1/10Broadridge Financial Solutions filed an 8-K reporting a routine headquarters relocation to 605 Third Avenue, New York, NOct 23, 2026
FISV8-Kneutral2/10Fiserv appointed Raj Seshadri, a former Mastercard executive, to its board effective November 30, 2026, and disclosed thOct 23, 2026
LKQ8-Kbearish8/10LKQ reported preliminary Q3 2026 results well below expectations, with revenue of $3.32B (down 5.1% YoY), a GAAP net losOct 23, 2026
AMR8-Kneutral4/10Alpha Metallurgical Resources reported preliminary Q3 2026 results with a net loss of $9.3M (-$0.73/diluted share) and AOct 23, 2026
FHB8-Kbearish6/10First Hawaiian reported Q3 2026 GAAP diluted EPS of $0.52, missing the $0.59 consensus by 11.9%, with net income of $63.Oct 23, 2026
NJR8-Kneutral3/10New Jersey Resources Corp's wholly-owned subsidiary, New Jersey Natural Gas Company, issued and sold $50 million of 5.43Oct 23, 2026
ORIC8-Kbullish7/10ORIC Pharmaceuticals presented updated Phase 1b data for enozertinib in 1L EGFR atypical NSCLC at ESMO 2026, showing an Oct 23, 2026
SXTP8-Kneutral4/1060 Degrees Pharmaceuticals filed an 8-K furnishing an updated investor presentation (October 23, 2026) detailing progresOct 23, 2026
GNTX8-Kbearish7/10Gentex reported Q3 2026 GAAP EPS of $0.43 on revenue of $647.7M, missing consensus estimates of $0.50 EPS and $669.6M reOct 23, 2026
NEUP8-Kneutral2/10Neuphoria Therapeutics extended the expiration date of its shareholder rights plan (poison pill) by one year, from OctobOct 23, 2026
RBCAA8-Kneutral5/10Republic Bancorp reported Q3 2026 net income of $31.1M and diluted EPS of $1.59, up 5% YoY from $1.52, driven by Core BaOct 23, 2026
WRLD8-Kbullish6/10World Acceptance Corporation reported Q2 FY2027 GAAP net income of $8.8M ($1.92/diluted share), a sharp turnaround from Oct 23, 2026
IPM8-Kneutral5/10IPM signed a definitive agreement to acquire AdTech's managed IT services business for up to $2.7 million in a two-stageOct 23, 2026
RITM8-Kbullish6/10Rithm Capital Corp. reported Q3 2026 GAAP net income of $217.1M ($0.38/diluted share) and Earnings Available for DistribOct 23, 2026
BCPC8-Kbullish6/10Balchem reported another strong quarter with record net sales, net earnings, and adjusted EBITDA, driven by growth acrosOct 23, 2026
SLB8-Kmixed5/10SLB reported Q3 2026 revenue of $9.45B (+6% YoY, +5% sequentially) and GAAP EPS of $0.49 (-2% YoY, -6% sequentially), buOct 23, 2026
JAKK8-Kbullish6/10JAKKS Pacific reported Q3 2026 net sales of $254.2M (+20% YoY) and GAAP diluted EPS of $2.48, significantly beating consOct 23, 2026
AXP8-Kbullish7/10American Express reported Q3 2026 adjusted EPS of $4.68, a 4.0% beat vs consensus of $4.50, on record revenue of $20.1B Oct 23, 2026
BAH8-Kbullish7/10Booz Allen Hamilton reported Q2 FY27 results with Adjusted Diluted EPS of $1.76, an 18.1% YoY increase and a 19.0% beat Oct 23, 2026
EAF8-Kbearish6/10GrafTech Q3 2026 net sales fell 3% YoY to $140M, net loss widened to $47M ($1.76/share) from $28M a year ago, including Oct 23, 2026
TNGX8-Kbullish7/10Tango Therapeutics reported highly promising Phase 1/2 data for vopimetostat + daraxonrasib in MTAP-deleted PDAC, showinOct 23, 2026
FCNCA8-Kbullish6/10First Citizens BancShares reported Q3 2026 adjusted EPS of $55.37, a 20.4% beat vs the $45.98 consensus, driven by stronOct 23, 2026
FIP8-Kmixed6/10FTAI Infrastructure's Jefferson Terminal subsidiary announced a $270 million private note offering to fund the $255 millOct 23, 2026
MKTX8-Kneutral4/10MarketAxess reported Q3 2026 GAAP EPS of $1.53, down 17% YoY, and revenue of $210.4 million, up 1% YoY. The miss was driOct 23, 2026
ALV8-Kbearish6/10Autoliv reported Q3 2026 results with net sales of $2,693 million (-0.5% YoY), GAAP diluted EPS of $2.13 (-6.8% YoY), anOct 23, 2026
ZYME8-Kbullish7/10Zymeworks entered into an exclusive global license and collaboration agreement with Roche for ZW209, a trispecific T-celOct 23, 2026
« Previous Page 34 of 334 Next »